Mr. Speaker, provincial and territorial governments, along with the Government of Canada, are part of the proposed class action commenced by British Columbia against 50 opioid manufacturers and distributors that allegedly acted inappropriately in the marketing and distribution of opioids. The defendant companies are listed in the attached addendum. One of those defendants was the Canadian entity of Purdue Pharma. In June 2022, British Columbia announced that it had reached a settlement with Purdue Pharma wherein Purdue agreed to pay $150 million for the Canadian governments’ claims. In December 2022, the B.C. court approved this Purdue settlement, as well as another out-of-court settlement negotiated by B.C. with the Roxane group of defendants. This legal action by British Columbia is ongoing as it relates to the remaining defendants, with multiple court hearings currently scheduled. British Columbia’s application to certify this proposed class action lawsuit in the B.C. Supreme Court is scheduled to be heard in the fall of 2023.
Provincial and territorial governments, along with the Government of Canada, are also part of the proposed class action commenced by British Columbia against McKinsey & Company, which allegedly acted inappropriately in the course of providing consulting services to opioid manufacturers and distributors. British Columbia commenced this proposed class action on behalf of all Canadian governments in December 2021. This legal action by British Columbia is still at a very early stage and is ongoing.
The list of defendants in British Columbia’s proposed class action is as follows: Sanis Health Inc., Shoppers Drug Mart Inc., McKesson Canada Corporation, Mylan Pharmaceuticals ULC, Sandoz Canada Inc., Apotex Inc., Apotex Pharmaceutical Holdings, Inc., Bristol-Myers Squibb Canada, Bristol Myers Squibb Company, Paladin Labs Inc., Endo Pharmaceuticals Inc., Endo International PLC, Endo ventures Ltd., Ethypharm Inc., Janssen Inc., Johnson & Johnson, Pharmascience Inc., Joddes Limited, Pro Doc Limitee, Le Groupe Jean Coutu (PJC) Inc., Purdue Pharma Inc., Purdue Pharma L.P., The Purdue Frederick Company Inc., Purdue Frederick Inc., Ranbaxy Pharmaceuticals Canada Inc., Sun Pharmaceutical Industries Ltd., Hikma Labs Ink., Hikma Pharmaceuticals PLC, Roxane Laboratories Inc., Boehringer Ingelheim Canada Ltd. or Boehringer Ingelheim Canada Ltee., West-Ward Columbus Inc., Teva Canada Innovation G.P.- S.E.N.C., Teva Canada Limited, Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd., Actavis Pharma Company, Valeant Canada LP or Valeant Canada S.E.C., Bausch Health Companies Inc., Imperial Distributors Canada Inc., Amerisourcebergen Canada Corporation, Kohl & Frisch Limited, Kohl & Frisch Distribution Inc., McKesson Corporation, Nu-Quest Distribution Inc., United Pharmacists Manitoba Inc., Procurity Inc., Procurity Pharmacy Services, Unipharm Wholesale Drugs, LPG Inventory Solutions and Normaco Inc.